Rifaximin pharmacology and clinical implications

MLA

Ojetti, Veronica, et al. “Rifaximin Pharmacology and Clinical Implications.” Expert Opinion on Drug Metabolism & Toxicology, vol. 5, no. 6, Jan. 2009, pp. 675–82. EBSCOhost, https://doi.org/10.1517/17425250902973695.

APA

Ojetti, V., Lauritano, E. C., Barbaro, F., Migneco, A., Ainora, M. E., Fontana, L., Gabrielli, M., & Gasbarrini, A. (2009). Rifaximin pharmacology and clinical implications. Expert Opinion on Drug Metabolism & Toxicology, 5(6), 675–682. https://doi.org/10.1517/17425250902973695

Chicago

Ojetti, Veronica, Ernesto Cristiano Lauritano, Federico Barbaro, Alessio Migneco, Maria Elena Ainora, Luigi Fontana, Maurizio Gabrielli, and Antonio Gasbarrini. 2009. “Rifaximin Pharmacology and Clinical Implications.” Expert Opinion on Drug Metabolism & Toxicology 5 (6): 675–82. doi:10.1517/17425250902973695.